Skip to main content

NEWS FLASH: AI Startups Are Reinventing Media | WIRED

NEWS FLASH: AI Startups Are Reinventing Media | WIRED: Over the last five years, processing power and huge corpuses of teaching data have given computers the ability to detect emotions and moods. Soon, perhaps, they will be able to recognize a sideline scuffle or a player’s shift in attitude. Combine that with sensors gathering crowd reactions, the movement and changes in velocity for players and passes, historical statistics that provide context for the game and a player’s performance—and now AI is starting to encroach on analysis as well.

As that definition of “reliable data” continues to expand, so too will AI applications. Here are a few AI-oriented ventures making inroads with content and media:

� Arria — Natural language generation platform that parses complex data sets, in any vertical, from finance to meteorology and writes expert-level reports formerly assigned to human analysts.

� Banjo — Ingests all types of digital signals from Twitter, Facebook and around the Web, to offer up the latest big stories faster than humans can discover them.

� Knotch — Analytics startup that helps brands, agencies, and publishers understand how their branded content impacts audiences.

� Narrative Science — Processes data, from weather to stock prices, to write news stories and insights.

These examples just scratch the surface of what businesses and researchers think AI can do for media. If they come through, these changes will raise complicated questions. What becomes of the media jobs AI eliminates? Who’s on the hook when machine intelligence gets the facts wrong or commits libel? These questions will likely require answers even more intelligent than the technology.

Popular posts from this blog

Elizabeth Holmes Discusses Theranos at WSJDLive 2015

Elizabeth Holmes Discusses Theranos at WSJDLive 2015 Elizabeth Holmes Discusses Theranos at WSJDLive 2015 At the WSJDLive 2015 conference, Theranos founder and CEO Elizabeth Holmes discusses her company's proprietary technologies, the FDA's inspection of its facilities, and the assertion that her company was too quick to market its products.